Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Significant expansion of biocatalysis, flow chemistry, and peptide capacity.
February 23, 2021
By: Tim Wright
Editor-in-Chief, Contract Pharma
Almac Sciences, a member of the Almac Group, has completed a roughly $7 million investment in a new two-storey center for biocatalysis, flow chemistry technologies and peptide research and development. Almac Sciences has grown rapidly over the last 5 years with significant investments in its non-GMP and GMP manufacturing plants to support increased client manufacturing demands. Adding to this growth, the first phase of expansion for technology development has been completed with the opening of a new facility housing additional R&D scientists to develop new technology and projects for Almac’s established biocatalysis, flow chemistry and peptides businesses. Additional capacity has also been created to enable further growth of its chemical development offering. The 2,000 square meter, two-storey dedicated technology center is located at the Group’s global headquarter campus and consists of 32 fume hoods, an engineering workshop for tooling and has capacity to accommodate up to 100 employees. Active recruitment for 20 additional staff members is underway and with a significant number of projects already commenced. The completion of this new facility further showcases Almac’s dedication to innovation and investment in technology as it continues to engineer its technology platforms for the pharmaceutical, biotechnology, life sciences and fine chemicals sectors and comes just months after Almac announced its multi-million pound investment to further develop a program to establish IN Silico Informed metaGenomic Harvesting Technology (INSIGHT) continuing its commitment to develop flow processes. “The investment in this new, state-of-the-art facility has been critical to support the rapid expansion of our innovative technology offering across different disciplines,” said Tom Moody, vice president of technology development and commercialization, Almac Sciences and Arran Chemical Company. “As our technology evolves, we are experiencing an ever-increasing pipeline of projects taking advantage of our integrated offering from development through to manufacture. It is an exciting time to be at Almac as our technology success breeds success. We look forward to driving innovation for our clients in this new center.” The next phase of development is currently underway with further announcements expected in the coming months.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !